Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer

Patrick C. Walsh

doi:10.1016/j.juro.2010.05.062

Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	956
Number of pages	1
Journal	Journal of Urology
Volume	184
Issue number	3
DOIs	https://doi.org/10.1016/j.juro.2010.05.062
State	Published - Sep 2010
Externally published	Yes

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2010.05.062

Cite this

@article{be61533e5a7f424292d32e6da3ed1779,

title = "Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer",

author = "Walsh, {Patrick C.}",

year = "2010",

month = sep,

doi = "10.1016/j.juro.2010.05.062",

language = "English (US)",

volume = "184",

pages = "956",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer

AU - Walsh, Patrick C.

PY - 2010/9

Y1 - 2010/9

UR - http://www.scopus.com/inward/record.url?scp=78049269548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049269548&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2010.05.062

DO - 10.1016/j.juro.2010.05.062

M3 - Comment/debate

AN - SCOPUS:78049269548

VL - 184

SP - 956

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3

ER -

Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this